Anebulo Pharmaceuticals Inc Cash Return on Assets (CROA) 2 year CAGR is 71.70% for the quarter ending March 31, 2024, a 365.73% change year over year. The cash return on assets ratio measures the profitability of a company's total assets based on its operating cash flow. It is calculated by dividing operating cash flow by total assets. This ratio indicates the company's ability to generate cash flow relative to its asset base. A higher ratio suggests more efficient utilization of assets in generating cash flow. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.